The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging

Fertility and Sterility

Volumn 94, Issue 2, 2010, Pages 694-700

  Fujii, Eriko Y ^a   Nakayama, Masahiro ^b  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b Aska Women's Clinic   (Japan)

Author keywords

AGEs; aging; CML; pentosidine; RAGE; reproduction; VEGF

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; VASCULOTROPIN;

ADULT; AGING; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; OOCYTE; OUTCOME ASSESSMENT; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; REPRODUCTION; STATISTICAL SIGNIFICANCE;

ADULT; AGE DISTRIBUTION; AGING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR FLUID; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; OOCYTE RETRIEVAL; OOCYTES; RECEPTORS, IMMUNOLOGIC; REPRODUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 77953727286     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.03.029     Document Type: Article

References (22)

1. Devangelio E., Santilli F., Formoso G., Ferroni P., Bucciarelli L., Michetti N., et al. Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med 43 (2007) 511-518
2. Onorato J.M., Thorpe S.R., and Baynes J.W. Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease. Ann N Y Acad Sci 20 854 (1998) 277-290
3. Boulanger E., Grossin N., Wautier M.P., Taamma R., and Wautier J.L. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int 71 (2007) 126-133
4. Print C., Valtola R., Evans A., Lessan K., Malik S., and Smith S. Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome. Hum Reprod 19 (2004) 2356-2366
5. Ma W., Lee S.E., Guo J., Qu W., Hudson B.I., Schmidt A.M., and Barile G.R. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest Ophthalmol Vis Sci 48 (2007) 1355-1361
6. Konishi H., Nakatsuka M., Chekir C., Noguchi S., Kamada Y., Sasaki A., and Hiramatsu Y. Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts. Hum Reprod 19 (2004) 2156-2162
7. Buhimschi I.A., Zhao G., Pettker C.M., Bahtiyar M.O., Maglorie L.K., Thung S., et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. AJOG 181 (2007) e1-12
8. Lu C., He J.C., Cai W., Liu H., Zhu L., and Vlassara H. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. PNAS 101 (2004) 11767-11772
9. Cooke C.L., Brockelsby J.C., Baker P.N., and Davidge S.T. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy 22 (2003) 173-184
10. Dunn J.A., McCance D.R., Thorpe S.R., Lyons T.J., and Baynes J.W. Age-dependent accumulation of N epsilon-(carboxymethyl) lysine and N epsilon-(carboxymethyl) hydroxylysine in human skin collagen. Biochemistry 30 (1991) 1205-1210
11. Gross S., van Ree R.M., Oterdoom L.H., de Vries A.P., van Son W.J., de Jong P.E., et al. Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients. Transplantation 15 (2007) 659-663
12. Nakamura K., Yamagishi S., Adachi H., Matsui T., Kurita-Nakamura Y., Takeuchi M., et al. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Diabetes Metab Res Rev 24 (2008) 109-114
13. Nakamura K., Yamagishi S.I., Matsui T., Adachi H., Takeuchi M., and Imaizumi T. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and nondiabetic subjects. Clin Exp Med 7 (2007) 188-190
14. Prevost G., Fajardy I., Besmond C., Balkau B., Tichet J., Fontaine P., et al., GENEDIAB and DESIR Study Groups. Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients. Diabetes Metab 31 (2005) 35-39
15. Fujii E.Y., Nakayama M., and Nakagawa A. Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis. Reprod Sci 15 (2008) 1066-1074
16. Kalousova M., Jachymova M., Mestek O., Hodkova M., Kazderova M., Tesar V., and Zima T. Receptor for advanced glycation end products-soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant 22 (2007) 2020-2026
17. Liliensiek B., Weigand M.A., Bierhaus A., Nicklas W., Kasper M., Hofer S., et al. Reeceptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. JCI 113 (2004) 1641-1650
18. Pullerits R., Bokarewa M., Dahlberg L., and Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7 (2005) 817-824
19. Stewart C., Cha S., Caudle R.M., Berg K., and Katz J. Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren's syndrome. Rheumatol Int 28 (2008) 771-776
20. Klein N.A., Battaglia D.E., Woodruff T.K., Padmanabhan V., Giudice L.C., Bremner W.J., and Soules M.R. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metab 85 (2000) 4520-4525
21. Manau D., Balasch J., Jiménez W., Fábregues F., Civico S., Casamitjana R., Creus M., and Vanrell J.A. Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response. Hum Reprod 15 (2000) 1295-1299
22. Benifla J.L., Bringuier A.F., Sifer C., Porcher R., Madelenat P., and Feldmann G. Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF. Hum Reprod 16 (2001) 1376-1381